|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,600.00 KRW | +6.73% |
|
-9.45% | -32.55% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.73% | -9.45% | -44.58% | - | 75.69M | ||
| -0.70% | +2.20% | +100.33% | +492.13% | 38.35B | ||
| -2.01% | +4.19% | +18.89% | +44.53% | 25.01B | ||
| -2.84% | +3.02% | -20.83% | -37.81% | 7.58B | ||
| +1.74% | +3.59% | +16.54% | +92.81% | 5.02B | ||
| +1.41% | +8.30% | +20.93% | +63.80% | 3.33B | ||
| -5.58% | +10.17% | -36.14% | +778.68% | 1.93B | ||
| -3.72% | +10.08% | +215.91% | -11.77% | 1.96B | ||
| +2.28% | +6.89% | -10.02% | -61.44% | 1.9B | ||
| +11.30% | +5.41% | +19.44% | +6.39% | 1.83B | ||
| Average | +0.86% | +4.34% | +28.05% | +151.92% | 8.7B | |
| Weighted average by Cap. | -0.89% | +3.59% | +53.82% | +250.26% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















